Distribuzione geografica
Continente #
NA - Nord America 2152
EU - Europa 973
AS - Asia 574
AF - Africa 5
Continente sconosciuto - Info sul continente non disponibili 3
SA - Sud America 2
Totale 3709
Nazione #
US - Stati Uniti d'America 2012
CN - Cina 547
IT - Italia 378
FI - Finlandia 182
IE - Irlanda 162
CA - Canada 139
UA - Ucraina 94
GB - Regno Unito 44
SE - Svezia 42
DE - Germania 37
FR - Francia 17
IN - India 9
NL - Olanda 8
TR - Turchia 6
EG - Egitto 5
IR - Iran 4
EU - Europa 3
VN - Vietnam 3
PH - Filippine 2
RS - Serbia 2
BE - Belgio 1
BG - Bulgaria 1
BR - Brasile 1
CH - Svizzera 1
CL - Cile 1
ID - Indonesia 1
KZ - Kazakistan 1
MK - Macedonia 1
MX - Messico 1
RO - Romania 1
RU - Federazione Russa 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
Totale 3709
Città #
Chandler 571
Millbury 282
Princeton 198
Nanjing 188
Ottawa 136
Jacksonville 114
Napoli 104
Beijing 90
Boston 90
Des Moines 85
Wilmington 69
Nanchang 64
Hebei 40
Jiaxing 38
Ann Arbor 33
Shenyang 33
Woodbridge 31
Lawrence 28
Houston 27
Tianjin 26
Norwalk 21
Changsha 18
Indiana 14
Naples 12
Falls Church 11
Caserta 9
Hangzhou 8
Pomigliano D'arco 8
Boise 7
Kunming 7
Changchun 6
Orange 6
Redmond 6
Ashburn 5
Boardman 5
Jinan 5
New York 5
Bologna 4
Brescia 4
Agropoli 3
Cercola 3
Chicago 3
Dung 3
Guangzhou 3
Lanzhou 3
Mumbai 3
Redwood City 3
Richland 3
Rome 3
Shenzhen 3
Acquaviva Delle Fonti 2
Augusta 2
Bari 2
Fremont 2
Marigliano 2
Mountain View 2
Palermo 2
Pozzuoli 2
Richmond 2
San Prisco 2
Sennori 2
Serra 2
Sesto San Giovanni 2
Shanghai 2
Simi Valley 2
Sorrento 2
Torino 2
Torre Annunziata 2
Torre Del Greco 2
Walnut 2
Zhengzhou 2
Acerra 1
Ardabil 1
Astana 1
Aversa 1
Burlington 1
Cairo 1
Caivano 1
Castagnaro 1
Castellammare di Stabia 1
Cava De' Tirreni 1
Chieti 1
Città Di Castello 1
Columbus 1
Downers Grove 1
Duncan 1
Ercolano 1
Florence 1
Fuzhou 1
Gent 1
Hanover 1
Iasi 1
Lewiston 1
Marano 1
Monterrey 1
Monza 1
New Haven 1
Ningbo 1
Nocera Inferiore 1
Pescantina 1
Totale 2512
Nome #
Hemolytic anemia during pegylated interferon alpha 2b plus ribavirin treatment for chronic hepatitis C: ribavirin is not always the culprit. A case report 61
CpG and Toll-like receptor 9 in primary biliary cirrhosis: a possible intracellular interaction from virus exposure? 53
Successful treatment of post-surgical osteomyelitis caused by XDR Pseudomonas aeruginosa with ceftolozane/tazobactam monotherapy 49
CD4+ T lymphocytes and cryoglobulins in patients coinfected with HIV and hepatitis C virus: forgetting the hidden CD4+ cell subsets. 46
The discovery of sofosbuvir: a revolution for therapy of chronic hepatitis C 45
Discontinued drugs in 2012 - 2013: Hepatitis C virus infection 41
Human Platelet Antigen Genotypes As Predictors of Liver Cirrhosis In Patients With Hcv Chronic Infection 40
HIV and hepatitis C virus: facts and controversies 38
A survey on antibiotic therapy knowledge among physicians of a tertiary care and university hospital 38
Rara e grave manifestazione dell’infezione da HHV-6: la sindrome DRESS. 37
Diagnostic Accuracy of PIVKA-II, Alpha-Fetoprotein and a Combination of both in Diagnosis of Hepatocellular Carcinoma in Patients Affected by Chronic HCV Infection 36
A Simple Noninvasive Score Based on Routine Parameters can Predict Liver Cirrhosis in Patients With Chronic Hepatitis C 35
Human immunodeficiency virus and subtype 1B hepatitis C virus: more similarities than differences in T-helper subsets. 34
Management of multidrug-resistant Pseudomonas aeruginosa in the intensive care unit: state of the art 34
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 34
Immunoglobulin superantigen protein L induces IL-4 and IL-13 secretion from human Fc epsilon RI+ cells through interaction with the kappa light chain of IgE 33
Asunaprevir for hepatitis C: A safety evaluation 33
TNF-alpha serum level elevations in chronic hepatitis C patients with diabetes mellitus. 32
Specific immunoglobulin against HCV: new perspectives. 32
ABT-450: A novel protease inhibitor for the treatment of hepatitis C virus infection 32
A Novel Promising Therapeutic Option Against Hepatitis C Virus: An Oral Nucleotide NS5B Polymerase Inhibitor Sofosbuvir 31
Beclabuvir for the treatment of hepatitis C 31
Human Platelet Antigen 3 Genotype Is An Independent Predictor of Platelet Count In Patients With Chronic Hepatitis C 30
Human platelet antigen 3 genotype predicts platelet count in patients with HCV infection 29
Low vitamin D levels are associated with the presence of serum cryoglobulins in patients with chronic HCV infection 29
Fecal microbiota transplantation for Clostridium difficile infection: Back to the future 29
Does compulsory vaccination limit personal freedom? Ethical issues 29
Immune system homeostasis during acute hepatitis C: viral escape or T-cell regulation? 27
Blood letting therapy in HCV-related iron overload - Part 1: Evaluation of clinical, hematological and hepatic parameters 27
The serum-ascites vitamin D gradient (SADG): A novel index in spontaneous bacterial peritonitis 27
Mutante lamivudino-resistente in paziente in profilassi con lamivudina in corso di chemioterapia antiblastica per linfoma non-Hodgkin: recupero clinico con terapia di associazione lamivudina e adefovir. 26
Asunaprevir, a protease inhibitor for the treatment of hepatitis C infection. 26
Investigational direct-acting antivirals in hepatitis C treatment: The latest drugs in clinical development 26
Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus 26
Bacterial and CMV pneumonia in a patient treated with alemtuzumab for multiple sclerosis 26
Current and emerging pharmacotherapy for the treatment of bacterial peritonitis 25
Antibiotic prophylaxis and risk of infections in thyroid surgery: Results from a national study (UEC - Italian Endocrine Surgery Units Association) 25
Studio sulla conoscenza dell’antibioticoterapia tra i medici di un ospedale universitario di terzo livello 25
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis 24
Compromissione cognitiva subclinica in pazienti HCV-positivi 24
The efficacy and safety of telaprevir - a new protease inhibitor against hepatitis C virus. 24
Blood in saliva of HIV seropositive drug abusers: possible implication in AIDS transmission. 24
Exposure to Varicella Zoster Virus is higher in children with autism spectrum disorder than in healthy controls. Results from a case-control study. 24
Epidemiology and Microbiology of Skin and Soft Tissue Infections: Preliminary Results of a National Registry 24
Sexual transmission of the hepatitis C virus and efficacy of prophylaxis with intramuscular immune serum globulin. A randomized controlled trial. 23
HCV and GBV-c/HGV infection in HIV positive patients in southern Italy. 23
Human immunodeficiency virus per se exerts atherogenic effects. 23
Blood In Saliva of Patients With Acquired-immunodeficiency-syndrome - Possible Implication In Sexual Transmission of the Disease 23
Aetiological association of virus like particles with hepatitis C. 23
Blood letting therapy in HCV-related iron overload - Part 2: Evaluation of HFE genetic mutation, HCV genotype and viral load 23
Anti-HBc positivity was associated with histological cirrhosis in patients with chronic hepatitis C. 23
The therapeutic potential of new investigational hepatitis C virus translation inhibitors 23
ITPase activity modulates the severity of anaemia in HCV-related cirrhosis treated with ribavirin-containing interferon-free regimens 23
[Clinical and diagnostic considerations on a case of pancreatic plasmacytoma]. 22
Detection of Hepatitis-c Virus-rna By Polymerase Chain-reaction In Dental Surgeries 22
Increased risk of virologic failure to the first antiretroviral regimen in HIV-infected migrants compared to natives: Data from the ICONA cohort 22
Prevalence of Congenital Cytomegalovirus Infection Assessed Through Viral Genome Detection in Dried Blood Spots in Children with Autism Spectrum Disorders 22
Active HCV Replication but Not HCV or CMV Seropositive Status Is Associated with Incident and Prevalent Type 2 Diabetes in Persons Living with HIV 22
Direct acting antiviral agents and hepatocellular carcinoma development: Don't take it for granted 22
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 22
Increased serum concentrations of soluble HLA-class I antigens in hepatitis C virus related mixed cryoglobulinaemia. 21
Cytokine network during NASH and possible treatment selection. 21
Concomitant Interferon-alfa and chemotherapy in hepatitis C and colorectal cancer: a case report 21
Prevalenza di infezioni da CMV, HHV-6 o EBV in bambini con disturbi dello spettro autistico. 21
Decreased warfarin effects in elder with recurrent Clostridium difficile infection during fidaxomicin therapy: a case report 21
Long-term interferon-alpha therapy does not affect sex hormones in males with chronic hepatitis C. 20
Multivariate discriminant function based on six biochemical markers in blood can predict the cirrhotic evolution of chronic hepatitis. 20
Contamination By Hepatitis-b Surface-antigen In Dental Surgeries 20
Investigational nucleoside and nucleotide polymerase inhibitors and their use in treating hepatitis C virus 20
Sustained low influenza vaccination in health care workers after H1N1 pandemic: A cross sectional study in an Italian health care setting for at-risk patients 20
Efficacy and tolerability of switching to a dual therapy with darunavir/ritonavir plus raltegravir in HIV-infected patients with HIV-1 RNA ≤50 cp/mL 20
Prevalence of HSV1/2 congenital infection assessed through genome detection on dried blood spot in individuals with autism spectrum disorders 20
Myasthenia gravis during low-dose IFN-alpha therapy for chronic hepatitis C. 19
Pernicious anemia during IFN-alpha treatment for chronic hepatitis C 19
POEMS syndrome: clinical, pathological and immunological study of a case 18
Multivariate discriminant function based on six biochemical markers in blood can predict the cirrhotic evolution of chronic hepatitis 18
Homocysteine levels and sustained virological response to pegylated-interferon alpha2b plus ribavirin therapy for chronic hepatitis C: a prospective study. 18
Current evidence on the management of hepatitis B in pregnancy 18
Contaminazione da HBsAg (antigene di superficie del virus epatitico B) in ambiente odontoiatrico 18
A case of paracoccidioidomycosis: Experience with long-term therapy 18
[Intranuclear particles in chronic non-A, non-B hepatitis: what diagnostic significance?]. 18
Prevalence of circulating immunecomplexes and variations of complement fractions in HBV, HDV and HCV infections: statistical analysis and clinical correlations. 18
Acute hepatitis C in patients undergoing hemodialysis: experience with high-dose interferon therapy 18
Prevalence and risk factors of erectile dysfunction in patients with hepatitis B virus or hepatitis C virus or chronic liver disease: Results from a prospective study 18
Triglyceride/HDL ratio and its impact on the risk of diabetes mellitus development during ART 18
Incidence of DAA failure and the clinical impact of retreatment in real-life patients treated in the advanced stage of liver disease: Interim evaluations from the PITER network 18
Invasive pulmonary aspergillosis and pulmonary tuberculosis in a patient treated with infliximab for Crohn's disease 18
Treatment with direct-acting antivirals improves the clinical outcome in patients with HCV-related decompensated cirrhosis: results from an Italian real-life cohort (Liver Network Activity—LINA cohort) 18
Iron depletion before HCV antiviral therapy: A pilot, randomized, controlled trial. 17
Associate Editor 17
HCV-RNA survival as detected by PCR in the environment. 17
Ultrastructural effects of PCMS on mycelial-yeast transition in Histoplasma capsulatum. 17
[Epidemiology of rotavirus infections in a randomized study in various central-southern areas of our country]. 17
[Effect of the administration of Cardiostenol on experimental hepatitis in mice induced with MHV-3 virus]. 17
Ledipasvir : a novel synthetic antiviral for the treatment of HCV infection. 17
A pill a day keeps HCV away 17
What is the role of the new β-lactam/β-lactamase inhibitors ceftolozane/tazobactam and ceftazidime/avibactam? 17
Hepatitis B mother-to-child transmission and infants immunization: we have not come to the end of the story yet 17
Totale 2541
Categoria #
all - tutte 8115
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8115

Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/201878 0000 00 1330 17972
2018/2019269 22388 6100 5310 223331
2019/2020680 33311239 475 36 64311480
2020/2021350 29223724 3770 303 36183212
2021/20221113 5306 431 538 17679210556
2022/2023836 2348624135 162182 130 0000
Totale 3999